Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Repeated Sub-anesthetic Ketamine to Enhance Prolonged Exposure Therapy in Post-traumatic Stress Disorder: A Proof-of-concept Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03960658

Organisation Name: Minneapolis Veterans Affairs Medical Center

Overal Status: Completed

Start Date: April 3, 2019

Last Update: October 6, 2020

Lead Sponsor: Minneapolis Veterans Affairs Medical Center

Brief Summary: This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD. Participation in the study includes Ketamine infusions, which occur once a week for three weeks. PE therapy sessions will be scheduled one day after each infusion, and may continue up to 12 weeks. After completely therapy, there will be two monthly follow-up assessment visits.

Conditions:
  • Post-traumatic Stress Disorder


Total execution time in seconds: 0.1948139667511